KEYNOTE-B79 试验于去年 12 月开始,正在评估 CYAD-101 与化疗同时...查看全文
Spica2021-12-04 06:46
$Celyad Oncology(CYAD)$ 让我偷偷笑一会儿 //@Spica: 同种异体的CAR-T公司更是跌到了6500美金的白菜价Celyad Oncology(CYAD) 欧洲公司打折更多么?查看全文
产业链观察2021-07-21 04:54
药闻| 新兴的肿瘤疗法开发 CAR-T与shRNA平台结合。
2021年7月20日, 专注于发现和开发异基因平台(包括CAR-T和 shRNA 技术)治疗癌症的临床阶段生物技术公司 $Celyad Oncology(CYAD)$ 今天在公司管理团队主办的研发日上重点介绍了从 shRNA 平台开发的新型环状异体载体CAR T 候选药物以及基于 s...查看全文
$Celyad Oncology(CYAD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001564590-23-003305 Act: 34 Size: 95 KB 网页链接
$Celyad Oncology(CYAD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-23-023403 Act: 34 Size: 47 KB 网页链接
$Celyad Oncology(CYAD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-22-309541 Act: 34 Size: 33 KB 网页链接
$Celyad Oncology(CYAD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-22-282619 Act: 34 Size: 37 KB 网页链接
$Celyad Oncology(CYAD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-22-261297 Act: 34 Size: 28 KB 网页链接
$Celyad Oncology(CYAD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-22-247736 Act: 34 Size: 30 KB 网页链接
$Celyad Oncology(CYAD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-22-213013 Act: 34 Size: 7 MB 网页链接
$Celyad Oncology(CYAD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-22-207797 Act: 34 Size: 35 KB 网页链接
$Celyad Oncology(CYAD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-22-180725 Act: 34 Size: 28 KB 网页链接
$Celyad Oncology(CYAD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-22-143826 Act: 34 Size: 84 KB 网页链接